Indian Journal of Radiology Indian Journal of Radiology  

   Login   | Users online: 3204

Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size     


Year : 2015  |  Volume : 25  |  Issue : 2  |  Page : 121-128
Imaging for assessment of treatment response in hepatocellular carcinoma: Current update

Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA

Correspondence Address:
Prof. Dushyant V Sahani
Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, 55 Fruit St., White 270, Boston, Massachusetts - 02114
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-3026.155835

Rights and Permissions

Morphologic methods such as the Response Evaluation Criteria in Solid Tumors (RECIST) are considered as the gold standard for response assessment in the management of cancer. However, with the increasing clinical use of antineoplastic cytostatic agents and locoregional interventional therapies in hepatocellular carcinoma (HCC), conventional morphologic methods are confronting limitations in response assessment. Thus, there is an increasing interest in new imaging methods for response assessment, which can evaluate tumor biology such as vascular physiology, fibrosis, necrosis, and metabolism. In this review, we discuss various novel imaging methods for response assessment and compare them with the conventional ones in HCC.

Print this article     Email this article

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
  Citation Manager
 Access Statistics
  Reader Comments
  Email Alert *
  Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded557    
    Comments [Add]    

Recommend this journal